Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc.verified

VTYX

Price:

$4.73

Market Cap:

$333.46M

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that is in phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of syst...[Read more]

Industry

Biotechnology

IPO Date

2021-10-21

Stock Exchange

NASDAQ

Ticker

VTYX

The Current Ratio as of May 2024 (TTM) for Ventyx Biosciences, Inc. (VTYX) is 22.00

According to Ventyx Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 22.00. This represents a change of 39.83% compared to the average of 15.73 of the last 4 quarters.

Ventyx Biosciences, Inc. (VTYX) Historical Current Ratio (quarterly & annually)

How has VTYX Current Ratio performed in the past?

The mean historical Current Ratio of Ventyx Biosciences, Inc. over the last ten years is 10.85. The current 22.00 Current Ratio has changed 20.19% with respect to the historical average. Over the past ten years (40 quarters), VTYX's Current Ratio was at its highest in in the March 2023 quarter at 23.44. The Current Ratio was at its lowest in in the September 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

10.85

Median

11.87

Minimum

0.17

Maximum

21.41

Ventyx Biosciences, Inc. (VTYX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Ventyx Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 12.16%

Maximum Annual Current Ratio = 21.41

Minimum Annual Increase = -68.43%

Minimum Annual Current Ratio = 0.17

Quarterly (TTM)
Annual
YearCurrent RatioChange
202311.87-41.27%
202220.21-5.60%
202121.4112.16%
20200.17-68.43%

Ventyx Biosciences, Inc. (VTYX) Average Current Ratio

How has VTYX Current Ratio performed in the past?

The current Current Ratio of Ventyx Biosciences, Inc. (VTYX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

17.83

5-year avg

10.85

10-year avg

10.85

Ventyx Biosciences, Inc. (VTYX) Current Ratio vs. Peers

How is VTYX’s Current Ratio compared to its peers?

Ventyx Biosciences, Inc.’s Current Ratio is greater than Arcellx, Inc. (5.46), greater than Immunocore Holdings plc (5.96), greater than Vaxcyte, Inc. (17.42), less than DICE Therapeutics, Inc. (25.88), greater than Nuvalent, Inc. (20.93), greater than Cerevel Therapeutics Holdings, Inc. (10.22), greater than Travere Therapeutics, Inc. (2.78), greater than Structure Therapeutics Inc. (19.05), less than Replimune Group, Inc. (0), greater than Ascendis Pharma A/S (10.72), greater than United Therapeutics Corporation (0.83), greater than IDEAYA Biosciences, Inc. (3.77), less than Protagonist Therapeutics, Inc. (28.42), greater than Verona Pharma plc (15.72), greater than Syndax Pharmaceuticals, Inc. (18.40), greater than null (8.93),

Build a custom stock screener for Ventyx Biosciences, Inc. (VTYX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ventyx Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ventyx Biosciences, Inc. (VTYX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ventyx Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Ventyx Biosciences, Inc.'s Current Ratio?

How is the Current Ratio calculated for Ventyx Biosciences, Inc. (VTYX)?

What is the highest Current Ratio for Ventyx Biosciences, Inc. (VTYX)?

What is the 3-year average Current Ratio for Ventyx Biosciences, Inc. (VTYX)?

What is the 5-year average Current Ratio for Ventyx Biosciences, Inc. (VTYX)?

How does the current Current Ratio for Ventyx Biosciences, Inc. (VTYX) compare to its historical average?